美女免费一级视频在线观看

The year is coming to a close and we here at MM+M are in a reflective mood.

Taking a look back on our coverage throughout 2024, we got to report on a number of developments that have reshaped the industry. 

From deals across the pharma, biotech and medical marketing spaces, to executive changes, analysis on policies and trends, we’ve covered it all. 

The editorial team has also shaken things up with the addition of two new members — editor in chief Jameson Fleming and reporter Heerea Rikhraj. 

As we look back on the past year, managing editor Jack O’Brien, editor-at-large Marc Iskowitz and senior pharma editor Lecia Bushak share their favorite/most impactful pieces. 

Jameson Fleming: How MM+M’s Best Places to Work create people-first workplaces 

Jameson is a firm believer that one of the most important things trade publications like MM+M can do is highlight strong workplace behavior. 

“We cover the industry and the trends that impact it, but we also have the opportunity to speak directly to specific categories of business that are all navigating the same talent issues,” said Jameson.

That’s why he loves opportunities to highlight the best workplace features or benefits the industry has to offer. 

These are pieces of information that empower employees to take successful training programs, workplace culture building ideas and inclusion initiatives directly to their leadership teams and demand better from their companies. 

It also shows employees at companies where workplace culture is nonexistent that there are greener pastures elsewhere.

In this story, Jameson combed through over 200 pages of testimonials about healthcare marketing agencies to pull out some of the most interesting and successful innovations happening there.

Jack O’Brien: Pfizer CMO Drew Panayiotou to leave company, will be replaced by Susan Rienow 

Jack’s favorite/most important story of the year was breaking the news that Pfizer global chief marketing officer Drew Panayiotou would leave the company. 

Panayiotou joined Pfizer in September 2022 and oversaw significant changes to the company’s marketing strategy, including an agency consolidation and a brand refresh. 

Under his watch, the company produced its first 60-second Super Bowl ad — Here’s to Science — which aired in February. 

“From a reporting perspective, I received a tip in the late afternoon and was able to get it confirmed so the story was published within the hour. Those kinds of scoops are one part of the reason our audience relies on MM+M for industry news,” said Jack. 

Marc Iskowitz: “More sioled than ever”: Pharma’s deep digital connect 

Marc said his most impactful piece this past year was an analysis on the disconnect between digital innovation and execution across the pharmaceutical industry. 

The piece delves into the struggle pharmaceutical companies face getting their new digital tools to consumers. 

While there are examples of corporate integration taking place, driving change remains extremely difficult for this industry, even for those that try to blow up their entire marketing organization in the process. 

Hopefully, this piece helped spur change in the way the industry approaches its digital communications. 

Lecia Bushak: Will AI Kill the health influencer?

As healthcare marketers increasingly embrace TikTok and influencer partnerships, they still face plenty of existential questions around brand safety, ethics — and even the emergence of “AI influencers.” 

Lecia’s story explored the rise of AI influencers partnering with brands and whether this trend would make a mark in the healthcare marketing world.

“I enjoyed reporting this piece because I got a chance to speak with a wide variety of experts — including popular physician influencer Dr. Karan Rajan, a ‘patient’ influencer who focuses on endometriosis, social media leaders at agencies, and even researchers who have been examining the impact of AI influencers in marketing,” she said. 

The story explored what authenticity means for brands when they partner with influencers — and whether AI avatars would be more successful at channeling it than humans. 

While some see promise in AI influencers, others see them as the “opposite of authenticity.” Most of the influencers she spoke with said their audiences still prefer the human element of their engagement — and that’s perhaps the biggest takeaway for marketers.

Heerea Rikhraj: Pharmacies keep closing: How can medical marketers bridge the gap for patients?

As pharmacies across the country keep shutting down, consumers grow weary of the new digital products the industry is pushing out to replace them. It’s important for healthcare marketers and agencies to respond to growing fears, and get products to patients who need it the most. 

MM+M is in a position where we can speak to the industry about things that really matter in people’s lives. 

That’s why writing a story about how the industry can respond to pharmacy shutdowns is critical. Heerea enjoyed writing this piece because it gave her the chance to look at gaps in care and figure out how the industry and health marketers can work to fill the gap. 

“I particularly liked being able to talk to so many innovative and resourceful people across the industry to center solutions around access to care,” said Heerea. 

At MM+M, we believe it’s our role to facilitate ongoing conversations around health access and equity, which is why we are happy to craft stories like this as part of our coverage.